Technical Analysis for XLO - Xilio Therapeutics, Inc.

Grade Last Price % Change Price Change
D 9.69 -19.25% -2.31
XLO closed down 19.25 percent on Tuesday, December 7, 2021, on 2.66 times normal volume. The bears made the stock sink to a new 52-week low. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong N/A N/A Down
Historical XLO trend table...

Date Alert Name Type % Chg
New 52 Week Closing Low Bearish 0.00%
Lower Bollinger Band Walk Weakness 0.00%
New 52 Week Low Weakness 0.00%
Multiple of Ten Bearish Other 0.00%
Outside Day Range Expansion 0.00%
Wide Bands Range Expansion 0.00%
Below Lower BB Weakness 0.00%
Down 3 Days in a Row Weakness 0.00%
Down 4 Days in a Row Weakness 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Older End-of-Day Signals for XLO ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
2x Volume Pace about 11 hours ago
Down 1 ATR about 11 hours ago
1.5x Volume Pace about 11 hours ago
Down 10% about 11 hours ago
Outside Day about 12 hours ago
View Earlier Intraday Alerts

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Xilio Therapeutics, Inc., a biotechnology company, designs immunotherapies to improve the immune system for cancer patients. Its checkpoint inhibitor programs include XTX101, is a clinical-stage, tumor-selective anti-CTLA-4 mAb that is in Phase 1 clinical trials in patients with solid tumors; and cytokine programs comprise XTX202, XTX301, and XTX401, which are modified form of IL-2 that is masked with a protein domain to prevent binding activity until cleaved off by tumor microenvironment (TME)-associated proteases. Xilio Therapeutics, Inc. was incorporated in 2020 and is headquartered in Waltham, Massachusetts.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biotechnology Cancer Clinical Medicine Solid Tumors Immune System Immunotherapy Cancer Immunotherapy Tumor Immunotherapies Checkpoint Inhibitor Immune Checkpoint Tumor Microenvironment

Is XLO a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 27.6725
52 Week Low 8.715
Average Volume 143,188
200-Day Moving Average 0.00
50-Day Moving Average 0.00
20-Day Moving Average 19.58
10-Day Moving Average 15.82
Average True Range 2.99
ADX 37.89
+DI 11.71
-DI 27.62
Chandelier Exit (Long, 3 ATRs) 18.72
Chandelier Exit (Short, 3 ATRs) 17.67
Upper Bollinger Bands 28.83
Lower Bollinger Band 10.32
Percent B (%b) -0.03
BandWidth 94.53
MACD Line -2.03
MACD Signal Line -0.66
MACD Histogram -1.3681
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 16.72
Resistance 3 (R3) 17.17 15.29 15.55
Resistance 2 (R2) 15.29 13.50 15.06 15.16
Resistance 1 (R1) 12.49 12.39 11.55 12.03 14.77
Pivot Point 10.60 10.60 10.13 10.37 10.60
Support 1 (S1) 7.80 8.81 6.86 7.35 4.61
Support 2 (S2) 5.92 7.71 5.69 4.22
Support 3 (S3) 3.12 5.92 3.83
Support 4 (S4) 2.66